Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine.

Literature DB >> 1997425

Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine.

B D Forrest¹, J T LaBrooy, P Robinson, C E Dearlove, D J Shearman.

Abstract

Specific antibody responses in the lower respiratory tract of human subjects to orally administered Salmonella typhi Ty21a are reported. These responses, predominantly of the immunoglobulin G class, were determined to be a transudate from serum. These results were supported by the similarity in responses to parenteral administration of heat-killed typhoid vaccine. Specific immunoglobulin A antibody was a poor contributor to the respiratory antibody response to either vaccine.

Entities: Species

Mesh：

Substances：

Year: 1991 PMID： 1997425 PMCID： PMC258392 DOI： 10.1128/iai.59.3.1206-1209.1991

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

11 in total

1. Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors: G Mancini; A O Carbonara; J F Heremans
Journal: Immunochemistry Date: 1965-09

2. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine.

Authors: P L Ogra; D T Karzon
Journal: J Immunol Date: 1969-06 Impact factor: 5.422

Review 3. The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors: J Mestecky
Journal: J Clin Immunol Date: 1987-07 Impact factor: 8.317

4. Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans.

Authors: B D Forrest; J T LaBrooy; S R Attridge; G Boehm; L Beyer; R Morona; D J Shearman; D Rowley
Journal: J Infect Dis Date: 1989-01 Impact factor: 5.226

5. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen.

Authors: J Mestecky; J R McGhee; R R Arnold; S M Michalek; S J Prince; J L Babb
Journal: J Clin Invest Date: 1978-03 Impact factor: 14.808

6. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system.

Authors: P Weisz-Carrington; M E Roux; M McWilliams; J M PHILLIPS-Quagliata; M E Lamm
Journal: J Immunol Date: 1979-10 Impact factor: 5.422

7. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors: C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal: Infect Immun Date: 1990-06 Impact factor: 3.441

8. Specific immune response in humans following rectal delivery of live typhoid vaccine.

Authors: B D Forrest; D J Shearman; J T LaBrooy
Journal: Vaccine Date: 1990-06 Impact factor: 3.641

Review 9. Bronchoalveolar lavage.

Authors: H Y Reynolds
Journal: Am Rev Respir Dis Date: 1987-01

10. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.

Authors: D K Wagner; M L Clements; C B Reimer; M Snyder; D L Nelson; B R Murphy
Journal: J Clin Microbiol Date: 1987-03 Impact factor: 5.948

11 in total

1. Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.

Authors: B D Forrest
Journal: Infect Immun Date: 1992-05 Impact factor: 3.441

Review 2. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

Authors: D T O'Hagan
Journal: Clin Pharmacokinet Date: 1992-01 Impact factor: 6.447

3. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.

Authors: J F Viret; D Favre; B Wegmüller; C Herzog; J U Que; S J Cryz; A B Lang
Journal: Infect Immun Date: 1999-07 Impact factor: 3.441

4. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain.

Authors: D Nardelli-Haefliger; J P Kraehenbuhl; R Curtiss; F Schodel; A Potts; S Kelly; P De Grandi
Journal: Infect Immun Date: 1996-12 Impact factor: 3.441

5. Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.

Authors: Lindsay J Hall; Simon Clare; Derek Pickard; Simon O Clark; Dominic L F Kelly; Moataz Abd El Ghany; Christine Hale; Jes Dietrich; Peter Andersen; Philip D Marsh; Gordon Dougan
Journal: Vaccine Date: 2009-09-13 Impact factor: 3.641

6. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.

Authors: Rezwanul Wahid; Shah J Zafar; Monica A McArthur; Marcela F Pasetti; Myron M Levine; Marcelo B Sztein
Journal: Clin Vaccine Immunol Date: 2014-01-15

7. Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.

Authors: C P Mallett; T L Hale; R W Kaminski; T Larsen; N Orr; D Cohen; G H Lowell
Journal: Infect Immun Date: 1995-06 Impact factor: 3.441